Hemostasis Disorders

• CLINICAL_TRIALS research · 2025-08-28
  Clinical Trial Update: Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study [NA]

  A completed clinical trial comparing sublingual estradiol versus oral estradiol with cyproterone acetate in transgender women, focusing on e…

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting [NA]

  A completed clinical trial evaluating HemoStyp as an adjunct to manage secondary hemostasis during surgery, with results posted in 2020.

• EMA withdrawal · 2018-10-10
  EMA Withdrawn: Raplixa (human fibrinogen;human thrombin) — Mallinckrodt Pharmaceuticals Ireland Limited

  Raplixa, a human fibrinogen and human thrombin product, has been withdrawn from the market by Mallinckrodt Pharmaceuticals Ireland Limited.

• EMA withdrawal · 2018-04-03
  EMA Withdrawn: Evarrest (human fibrinogen;human thrombin) — Omrix Biopharmaceuticals N. V.

  Evarrest (human fibrinogen; human thrombin) has been withdrawn from EMA authorization.